XRTX logo

XORTX Therapeutics Inc. (XRTX)

Profile

Full Name

XORTX Therapeutics Inc.

Ticker

NASDAQ: XRTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

September 23, 2021

Indexes

Not included

Website

https://www.xortx.com

Employees

2

Key Details

Price

$0.83(+1.85%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.15(-5.50% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.83
    XRTX price is $0.83

    30-Day Relative Volume

    1.44
    XRTX 30-day relative volume is 1.44

    Price Performance

    Price Most recent change

    +1.85%
    XRTX price was up +1.85% on Sep 12, 2025

    Price YTD change

    -26.9%
    XRTX price is down -26.9% since January 1st

    Price 1-year change

    -51.41%
    XRTX price is down -51.41% year-on-year

    Price 3-year change

    -99.23%
    XRTX price is down -99.23% over the past 3 years

    Price Range

    Price All-time high

    $495.72
    XRTX price is currently -99.83% below its historical high of $495.72

    Price 3-year low

    $0.66
    XRTX price is currently +24.96% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.31M
    XRTX market capitalization is $4.31 million

    Market cap 3-year change

    -97.21%
    XRTX market capitalization is down -97.21% over the past 3 years

    Market cap All-time high

    $501.15M
    XRTX market capitalization is currently -99.14% below its historical high of $501.15 million

    Market cap sector rank

    8.58%
    XRTX market capitalization is higher than 8.58% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +79.51%
    XRTX shares outstanding is up +79.51% year-on-year

    Shares Outstanding 3-Year Change

    +261.13%
    XRTX shares outstanding is up +261.13% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.46
    XRTX beta is 0.46

    200-day SMA

    $0.96
    XRTX price is currently -13.96% below its 200-day simple moving average

    50-day SMA

    $0.83
    XRTX price is currently -0.73% below its 50-day simple moving average

    RSI

    50.63
    XRTX 14-day relative strength index is 50.63

    Volume

    1.44
    XRTX 30-day relative volume is 1.44

    ATR

    $0.06
    XRTX average true range is $0.06

    10-day Historical Volatility

    34.74%
    XRTX 10-day historical volatility is 34.74%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    XRTX annual revenue is $0.00

    Revenue Analysts estimate

    -
    XRTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    XRTX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.75%
    XRTX annual revenue is higher than 28.75% of companies in Healthcare sector

    EPS

    EPS

    -$1.15
    XRTX annual earnings per share is -$1.15

    EPS Analysts estimate

    -
    XRTX annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -5.5%
    XRTX annual earnings per share is down -5.5% year-on-year

    EPS Sector rank

    49.49%
    XRTX annual earnings per share is higher than 49.49% of companies in Healthcare sector

    Profit

    Gross profit

    -$117.30K
    XRTX annual gross profit is -$117.30 thousand

    Gross margin

    -
    XRTX annual gross profit margin value is unknown

    Operating profit

    -$4.12M
    XRTX annual operating income is -$4.12 million

    Operating margin

    -
    XRTX annual operating profit margin value is unknown

    Net income

    -$3.31M
    XRTX annual net profit is -$3.31 million

    Net margin

    -
    XRTX annual net profit margin value is unknown

    Expenses

    Total expenses

    $4.12M
    XRTX annual total expenses is $4.12 million

    Operating expenses

    $4.12M
    XRTX annual total operating expenses is $4.12 million

    Cost of goods sold

    $117.30K
    XRTX annual cost of goods sold is $117.30 thousand

    Selling, general & administrative expenses

    $2.28M
    XRTX annual SGA is $2.28 million

    Depreciation and amortization

    $117.30K
    XRTX annual depreciation & amortization is $117.30 thousand

    Interest expense

    $0.00
    XRTX annual interest expense is $0.00

    Income tax

    $0.00
    XRTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$4.12M
    XRTX annual earnings before interest & taxes is -$4.12 million

    EBITDA

    -$4.00M
    XRTX annual EBITDA is -$4.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $4.09M
    XRTX annual total assets is $4.09 million

    Non current assets

    $1.42M
    XRTX annual long term assets is $1.42 million

    Current assets

    $2.68M
    XRTX annual total current assets is $2.68 million

    Cash and cash equivalents

    $2.47M
    XRTX annual cash & cash equivalents is $2.47 million

    Accounts receivable

    $17.60K
    XRTX annual accounts receivable is $17.60 thousand

    Inventory

    $0.00
    XRTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $758.00K
    XRTX annual total liabilities is $758.00 thousand

    Long term liabilities

    $0.00
    XRTX annual total long term liabilities is $0.00

    Current liabilities

    $758.00K
    XRTX annual total current liabilities is $758.00 thousand

    Accounts payable

    $0.00
    XRTX annual accounts payable is $0.00

    Debt

    Total debt

    $38.80K
    XRTX annual total debt is $38.80 thousand

    Total debt 1-year change

    +237.39%
    XRTX annual total debt is up +237.39% year-on-year

    Long term debt

    $0.00
    XRTX annual long term debt is $0.00

    Short term debt

    $38.80K
    XRTX annual short term debt is $38.80 thousand

    Equity & Capital

    Shareholders equity

    $3.34M
    XRTX annual stockholders equity is $3.34 million

    Book value

    $3.34M
    XRTX annual book value is $3.34 million

    Retained earnings

    -$21.17M
    XRTX annual retained earnings is -$21.17 million

    Working capital

    $1.92M
    XRTX annual working capital is $1.92 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$3.68M
    XRTX annual cash flow from operations is -$3.68 million

    Cash from operations 1-year change

    +44.12%
    XRTX annual cash flow from operations is up +44.12% year-on-year

    Cash from investing

    -$38.90K
    XRTX annual cash flow from investing activities is -$38.90 thousand

    Cash from investing 1-year change

    +16.16%
    XRTX annual cash flow from investing activities is up +16.16% year-on-year

    Cash from financing

    $2.78M
    XRTX annual cash flow from financing activities is $2.78 million

    Cash from financing 1-year change

    +869.94%
    XRTX annual cash flow from financing activities is up +869.94% year-on-year

    CAPEX

    CAPEX

    $38.90K
    XRTX annual capital expenditures is $38.90 thousand

    CAPEX 1-year change

    -16.16%
    XRTX annual capital expenditures is down -16.16% year-on-year

    Free Cash Flow

    Free cash flow

    -$3.72M
    XRTX annual free cash flow is -$3.72 million

    Free cash flow 1-year change

    +43.92%
    XRTX annual free cash flow is up +43.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    XRTX annual gross profit margin value is unknown

    Operating margin

    -
    XRTX annual operating profit margin value is unknown

    Net margin

    -
    XRTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -69.30%
    XRTX annual return on assets is -69.30%

    ROE

    -83.06%
    XRTX annual return on equity is -83.06%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    XRTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    XRTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.12
    XRTX price to book ratio is 2.12

    PB ratio Sector rank

    54.55%
    XRTX price to book ratio is higher than 54.55% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    XRTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    XRTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $3.32M
    XRTX enterprise value is $3.32 million

    Enterprise value Sector rank

    15.99%
    XRTX enterprise value is higher than 15.99% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.01
    XRTX EV/EBITDA is -1.01

    EV/EBITDA Sector rank

    47.27%
    XRTX EV/EBITDA is higher than 47.27% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.53
    XRTX annual current ratio is 3.53

    Quick ratio

    3.53
    XRTX annual quick ratio is 3.53

    Leverage

    Debt to equity

    0.01
    XRTX annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    XRTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    XRTX piotroski f-score value is unknown

    Altman Z-Score

    -6.59
    XRTX altman z-score is -6.59

    Analyst ratings

    Recent major analysts updates

    Dec 22, 21 Alliance Global Partners
    Buy
    Dec 9, 21 Alliance Global Partners
    Buy

    Institutional Ownership

    Screeners with XRTX included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for XORTX Therapeutics Inc.?
    • Does XORTX Therapeutics Inc. pay dividends?
    • What sector is XORTX Therapeutics Inc. in?
    • What industry is XORTX Therapeutics Inc. in?
    • What country is XORTX Therapeutics Inc. based in?
    • When did XORTX Therapeutics Inc. go public?
    • Is XORTX Therapeutics Inc. in the S&P 500?
    • Is XORTX Therapeutics Inc. in the NASDAQ 100?
    • Is XORTX Therapeutics Inc. in the Dow Jones?
    • When was XORTX Therapeutics Inc.'s last earnings report?
    • When does XORTX Therapeutics Inc. report earnings?

    What is the ticker symbol for XORTX Therapeutics Inc.?

    The ticker symbol for XORTX Therapeutics Inc. is NASDAQ:XRTX

    Does XORTX Therapeutics Inc. pay dividends?

    No, XORTX Therapeutics Inc. does not pay dividends

    What sector is XORTX Therapeutics Inc. in?

    XORTX Therapeutics Inc. is in the Healthcare sector

    What industry is XORTX Therapeutics Inc. in?

    XORTX Therapeutics Inc. is in the Biotechnology industry

    What country is XORTX Therapeutics Inc. based in?

    XORTX Therapeutics Inc. is headquartered in Canada

    When did XORTX Therapeutics Inc. go public?

    XORTX Therapeutics Inc.'s initial public offering (IPO) was on September 23, 2021

    Is XORTX Therapeutics Inc. in the S&P 500?

    No, XORTX Therapeutics Inc. is not included in the S&P 500 index

    Is XORTX Therapeutics Inc. in the NASDAQ 100?

    No, XORTX Therapeutics Inc. is not included in the NASDAQ 100 index

    Is XORTX Therapeutics Inc. in the Dow Jones?

    No, XORTX Therapeutics Inc. is not included in the Dow Jones index

    When was XORTX Therapeutics Inc.'s last earnings report?

    XORTX Therapeutics Inc.'s most recent earnings report was on April 7, 2014

    When does XORTX Therapeutics Inc. report earnings?

    The date for XORTX Therapeutics Inc.'s next earnings report has not been announced yet
    On this page